Published in RNA Biol on April 01, 2012
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol (2013) 2.44
A unique open reading frame within the comX gene of Streptococcus mutans regulates genetic competence and oxidative stress tolerance. Mol Microbiol (2015) 0.91
Identification of novel growth phase- and media-dependent small non-coding RNAs in Streptococcus pyogenes M49 using intergenic tiling arrays. BMC Genomics (2012) 0.91
Small regulatory RNAs from low-GC Gram-positive bacteria. RNA Biol (2014) 0.91
The Streptococcus suis transcriptional landscape reveals adaptation mechanisms in pig blood and cerebrospinal fluid. RNA (2014) 0.87
RNA regulators of host immunity and pathogen adaptive responses in the oral cavity. Microbes Infect (2015) 0.84
Multiple roles of RNase Y in Streptococcus pyogenes mRNA processing and degradation. J Bacteriol (2013) 0.80
Regulatory RNAs in the Less Studied Streptococcal Species: From Nomenclature to Identification. Front Microbiol (2016) 0.79
Genome-wide analyses of small non-coding RNAs in streptococci. Front Genet (2015) 0.78
RNA sequencing uncovers antisense RNAs and novel small RNAs in Streptococcus pyogenes. RNA Biol (2016) 0.76
The Mechanisms of Virulence Regulation by Small Noncoding RNAs in Low GC Gram-Positive Pathogens. Int J Mol Sci (2015) 0.75
Analysis of the small RNA P16/RgsA in the plant pathogen Pseudomonas syringae pv. tomato strain DC3000. Microbiology (2012) 0.75
Stress Physiology of Lactic Acid Bacteria. Microbiol Mol Biol Rev (2016) 0.75
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature (2011) 17.38
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol (2011) 17.11
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science (2014) 5.13
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol (2013) 2.44
Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res (2013) 2.35
Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol (2004) 1.92
Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information. Virology (2012) 1.80
Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis (2003) 1.56
Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J Biol Chem (2008) 1.38
Biotechnology: Rewriting a genome. Nature (2013) 1.27
Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci. J Infect Dis (2008) 1.24
The dark side of the salad: Salmonella typhimurium overcomes the innate immune response of Arabidopsis thaliana and shows an endopathogenic lifestyle. PLoS One (2008) 1.23
An overview of RNAs with regulatory functions in gram-positive bacteria. Cell Mol Life Sci (2009) 1.19
McsB is a protein arginine kinase that phosphorylates and inhibits the heat-shock regulator CtsR. Science (2009) 1.19
Functional analysis of the group A streptococcal luxS/AI-2 system in metabolism, adaptation to stress and interaction with host cells. BMC Microbiol (2008) 1.13
Structural basis for recognizing phosphoarginine and evolving residue-specific protein phosphatases in gram-positive bacteria. Cell Rep (2013) 0.83
A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway. FEBS Lett (2013) 0.78
The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity. Invest New Drugs (2010) 0.77
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells. Biochim Biophys Acta (2011) 0.77
Insertion sequence 1515 in the ply gene of a type 1 clinical isolate of Streptococcus pneumoniae abolishes pneumolysin expression. J Clin Microbiol (2007) 0.77
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent. Invest New Drugs (2014) 0.77
Editorial: RNA in bacteria: biogenesis, regulatory mechanisms and functions. FEMS Microbiol Rev (2015) 0.75